Report - AB-Biotics ROCE -12.0% 8.9% 26.3% Net Debt Equity 0.4 -0.3 -0 · AB-Biotics Page 3 Investment Case AB-Biotics is a biotechnology company strongly focused on the market and whose operating

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form